Effects of propranolol and swim-training on blood pressure, plasma electrolytes, and vasopressin in spontaneously hypertensive and normotensive rats. 1987

F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
Laboratoire de Physiologie, Faculté de Médecine Grange-Blanche, Lyon, France.

The aim of this work was to study the influence of beta-adrenoreceptor blockade on the adaptation to exercise of one of the hormonal systems (arginine vasopressin) involved in the regulation of blood volume and pressure in spontaneously hypertensive rats (SHR). Systolic blood pressure (SBP) was measured in SHR and WKY rats during 11 wk of swim training. At the end of the training program we determined post-exercise values of plasma arginine-vasopressin (pAVP), osmolality (pOsm), K+ (pK+), Na+ (pNa+), hemoglobin (Hgb), and hematocrit (Hct) in SHR and WKY rats. The following groups were studied: control (C), propranolol treated (PC), swim trained (S), and propranolol-treated and swim-treated (PS). SBP was significantly reduced by swim training or propranolol, bu these beneficial effects on SBP were attenuated when propranolol and swim training were combined. pNa+ and pOsm were significantly reduced by training alone in SHR. This reduction of pNa+ and, consequently, of pOsmol without any modification of other parameters could suggest an Na+ loss. In contrast, the SHR group treated with propranolol alone showed a significant reduction in Hct, suggesting an increased plasma volume without Na+ loss. PS SHR showed a significant reduction of Hgb, Hct, proteins, pNa+, and pOsmol, probably as a consequence of the additive effects of swimming- and propranolol-induced hypervolemia with Na+ loss. The slight and nonsignificant reduction in pAVP observed with either training or propranolol treatment alone became much more pronounced and statistically significant when the 2 treatments were combined. WKY rats showed a much smaller response to exercise and beta-adrenoreceptor blockade than SHR. We conclude that the hypervolemia suggested in PS SHR could be a possible cause of attenuation of the beneficial effects of either swimming or propranolol on SBP.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004573 Electrolytes Substances that dissociate into two or more ions, to some extent, in water. Solutions of electrolytes thus conduct an electric current and can be decomposed by it (ELECTROLYSIS). (Grant & Hackh's Chemical Dictionary, 5th ed) Electrolyte
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013550 Swimming An activity in which the body is propelled through water by specific movement of the arms and/or the legs. Swimming as propulsion through water by the movement of limbs, tail, or fins of animals is often studied as a form of PHYSICAL EXERTION or endurance.

Related Publications

F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
January 1990, Journal of cardiovascular pharmacology,
F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
March 1994, Japanese heart journal,
F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
December 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
January 1991, European journal of applied physiology and occupational physiology,
F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
January 1989, American journal of hypertension,
F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
January 1986, Clinical and experimental hypertension. Part A, Theory and practice,
F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
June 1992, Journal of the autonomic nervous system,
F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
February 2012, Canadian journal of physiology and pharmacology,
F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
January 1986, Physiology & behavior,
F Ghaemmaghami, and G Gauquelin, and G Geelen, and J Ibanez, and F Bouzeghrane, and F Cherbal, and C Meunier, and C Gharib
September 1990, European journal of pharmacology,
Copied contents to your clipboard!